A multicentre, three-armed randomised controlled trial published in Gut on 25 July 2026 set out to compare in-person therapist-delivered hypnotherapy, smartphone-based self-guided hypnotherapy, and a third condition in patients with irritable bowel syndrome. The study design, registered as a randomised controlled trial, is in principle well-suited to test whether delivery format affects treatment outcome. Beyond that, nothing about what the trial found can be reported here: no abstract was available at the time of this dispatch, so no results, effect sizes, sample size, blinding procedures, or conclusions can be confirmed or summarised.
This dispatch therefore cannot tell readers whether either hypnotherapy arm outperformed a control, whether smartphone delivery matched or fell short of therapist-delivered care, or whether the trial met its primary endpoint. All such claims would require access to the full text or a complete abstract, neither of which was available. Publication in a peer-reviewed journal indicates editorial scrutiny was applied, but that fact alone says nothing about the direction or size of any effects.
The study question carries genuine relevance to consciousness research. Hypnotherapy works, when it works, through suggestion and altered attentional states, and IBS is a condition in which visceral symptom perception is demonstrably shaped by top-down cognitive and expectational processes. A well-powered trial comparing human-delivered versus self-guided digital hypnotherapy could, in principle, say something about how much of any benefit depends on the relational and intersubjective context of suggestion versus the content of the hypnotic script alone. Whether this trial does say that remains unknown until its findings are accessible.
Readers with institutional access are encouraged to consult the primary source directly. Source: https://pubmed.ncbi.nlm.nih.gov/42502003/ (DOI: 10.1136/gutjnl-2026-338385).